Here, LRIG1 was found to be significantly upregulated in symptomatic AD vs. non-symptomatic AD patients, suggesting that neurogenic outcome in these individuals could offset the clinical manifestation of dementia. This evidence concerns the gene LRIG1 and Alzheimer disease.